Christopher B. Primiano

2016

In 2016, Christopher B. Primiano earned a total compensation of $671.7K as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 84% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$122,000
Option Awards$178,476
Salary$360,000
Other$11,260
Total$671,736

Primiano received $360K in salary, accounting for 54% of the total pay in 2016.

Primiano also received $122K in non-equity incentive plan, $178.5K in option awards and $11.3K in other compensation.

Rankings

In 2016, Christopher B. Primiano's compensation ranked 10,071st out of 14,075 executives tracked by ExecPay. In other words, Primiano earned more than 28.4% of executives.

ClassificationRankingPercentile
All
10,071
out of 14,075
28th
Division
Manufacturing
3,890
out of 5,489
29th
Major group
Chemicals And Allied Products
1,370
out of 1,895
28th
Industry group
Drugs
1,095
out of 1,538
29th
Industry
Pharmaceutical Preparations
859
out of 1,176
27th
Source: SEC filing on April 27, 2018.

Primiano's colleagues

We found three more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2016.

2016

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2016

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2016

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

News

You may also like